Methyl jasmonate (MJ) is a hexokinase-II inhibitor that can inhibit tumor cell proliferation by blocking glycolysis through disrupting the interaction between VDAC and HK-II on the mitochondrial membrane. The gene discussed is HK2; the disease is neoplasm.